Develops drugs for attention deficit hyperactivity disorder and moderate pain.
Jun 2026Revenue $808M/yrExpenses $651M/yr
Reached break-even Oct 2022
Figures by year
When did Collegium Pharmaceutical become profitable?
Its revenue passed its expenses in Oct 2022. In the 12 months to Jun 2026, revenue was $808M and expenses $651M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $781M | $601M | $180M |
| Dec 2024 | $631M | $462M | $170M |
| Dec 2023 | $567M | $400M | $167M |
| Dec 2022 | $464M | $431M | $33.3M |
| Dec 2021 | $277M | $259M | $17.6M |
| Dec 2020 | $310M | $254M | $56.2M |
| Dec 2019 | $297M | $320M | −$23.7M |
| Dec 2018 | $280M | $301M | −$20.7M |
| Dec 2017 | $28.5M | $104M | −$75.4M |
| Dec 2016 | $1.71M | $95.8M | −$94.1M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.